- Home
- EQR vs BNTX Comparison
EQR vs BNTX Comparison
Compare EQR & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQR
- BNTX
- Stock Information
- Founded
- EQR 1993
- BNTX 2008
- Country
- EQR United States
- BNTX Germany
- Employees
- EQR N/A
- BNTX N/A
- Industry
- EQR Real Estate Investment Trusts
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EQR Real Estate
- BNTX Health Care
- Exchange
- EQR Nasdaq
- BNTX Nasdaq
- Market Cap
- EQR 27.9B
- BNTX 23.9B
- IPO Year
- EQR 1993
- BNTX 2019
- Fundamental
- Price
- EQR $73.81
- BNTX $120.69
- Analyst Decision
- EQR Buy
- BNTX Strong Buy
- Analyst Count
- EQR 18
- BNTX 15
- Target Price
- EQR $76.24
- BNTX $143.50
- AVG Volume (30 Days)
- EQR 1.3M
- BNTX 1.0M
- Earning Date
- EQR 01-28-2025
- BNTX 11-04-2024
- Dividend Yield
- EQR 3.65%
- BNTX N/A
- EPS Growth
- EQR 35.67
- BNTX N/A
- EPS
- EQR 2.44
- BNTX N/A
- Revenue
- EQR $2,940,829,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- EQR N/A
- BNTX N/A
- Revenue Next Year
- EQR $4.01
- BNTX N/A
- P/E Ratio
- EQR $30.33
- BNTX N/A
- Revenue Growth
- EQR 3.33
- BNTX N/A
- 52 Week Low
- EQR $57.33
- BNTX $76.53
- 52 Week High
- EQR $78.83
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- EQR 48.33
- BNTX 57.89
- Support Level
- EQR $72.51
- BNTX $116.73
- Resistance Level
- EQR $73.97
- BNTX $123.29
- Average True Range (ATR)
- EQR 1.11
- BNTX 4.70
- MACD
- EQR -0.27
- BNTX 0.54
- Stochastic Oscillator
- EQR 22.38
- BNTX 73.82
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 299 apartment communities with around 80,000 units and is developing three additional properties with 977 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.